Pinwheel Therapeutics

BiotechnologySeries AUS

Latest round

Series A

Last raised

Feb 2026

Total raised

$20M

Investors

2

About Pinwheel Therapeutics

Based in the US, Pinwheel Therapeutics is a clinical stage biopharmaceutical company focused on the development of therapeutic assets for emergency anticoagulation management. Pinwheel’s lead asset, Ciraparantag, is a small molecule therapy manufactured using peptide chemistry. It is designed to reverse multiple classes of anticoagulants, including direct oral Factor Xa inhibitors, direct thrombin inhibitors, and both low molecular weight and unfractionated heparins. The therapy is being developed as a universal reversal option delivered via a ready to use intravenous injection for emergency settings such as trauma, intracranial hemorrhage, and urgent surgery.

Who invested in Pinwheel Therapeutics

2 investors across 1 round

See all investors in Pinwheel Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Feb 4, 2026

    Amount

    $20M

    Investors

    Locked

Questions about Pinwheel Therapeutics

Who invested in Pinwheel Therapeutics?

Pinwheel Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Pinwheel Therapeutics raised?

Pinwheel Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Pinwheel Therapeutics last raise money?

Pinwheel Therapeutics's most recent round on record is a Series A, in Feb 2026.

What does Pinwheel Therapeutics do?

Based in the US, Pinwheel Therapeutics is a clinical stage biopharmaceutical company focused on the development of therapeutic assets for emergency anticoagulation management.

Where is Pinwheel Therapeutics headquartered?

Pinwheel Therapeutics is headquartered in US.

Which VCs invest in companies like Pinwheel Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pinwheel Therapeutics's stage. Their profiles are linked below.

Raising like Pinwheel Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.